Health Atlas
Menu
Evidence-led reference

Glyphosate and Roundup: what does the cancer evidence tell us?

Separate the ingredient, the product and the way exposure happens.

15 sources · Latest source check 2026-10-15 UTC
On this page

Glyphosate controls unwanted plants by blocking an enzyme needed for plant growth. It is used in agriculture and other settings. Questions about applying a formulated herbicide, measuring residues in food and classifying cancer evidence are related, but they do not describe the same exposure or outcome.[1]

What does this actually mean?

The meaning

Glyphosate is an ingredient that kills weeds; Roundup is a brand name. They are not interchangeable names for one chemical mixture. Glyphosate appears in different products, while some current US consumer Roundup products use other active ingredients, such as triclopyr, fluazifop and diquat. A bottle bought years ago, a farm product and a new garden spray may therefore have different contents. Read the active-ingredient panel and the directions on that particular bottle.[11]

Familiar examples

Finding a residue in cereal and getting spray on your hands are different exposure situations. For food, the questions include the measured concentration, how much is eaten and how often. During mixing or spraying, skin, eye and breathing exposures can occur, alongside contact with other ingredients in the formulation. The same chemical name does not establish the same absorbed dose or health risk across those situations.[12][13]

What the cancer label means

IARC’s “probably carcinogenic” category reflects limited human and sufficient animal cancer evidence, not a probability of cancer from breakfast.[3]

Why assessments differ

Other assessments reach different conclusions. EFSA’s 2023 review identified no critical areas of concern but recorded data gaps. ECHA also assesses cancer hazard, so the disagreement cannot be explained entirely as hazard versus risk. Its September 2026 account says the new Ramazzini study did not change its conclusion that cancer classification was unwarranted. Study selection, interpretation and assessment rules matter. These are assessments of evidence, not guarantees about every exposure or every formulated product.[5][14]

What human research supports

The Agricultural Health Study followed licensed pesticide applicators, rather than people assigned to eat a particular cereal. Its updated analysis found no association with overall cancer or non-Hodgkin lymphoma, while a signal for acute myeloid leukemia at higher exposure required further follow-up. An observational null result does not prove that every dose or formulation has no effect; a subgroup signal does not establish that food residues cause that disease.[6]

What is still being examined

The 2025 Ramazzini experiment reported increased tumors in rats exposed from prenatal life to glyphosate or two formulations. Animal findings inform hazard assessment; they are not a direct estimate of cancer risk from a normal meal. In September 2026, EPA announced further work on formulations, dietary exposure and occupational evidence as part of its ongoing reassessment. That announcement was not a completed new cancer verdict.[8][15]

What to check

For a weedkiller purchase, check the actual ingredients, intended use, required protection and instructions for keeping people away from treated areas. A familiar brand or a glyphosate-free claim cannot substitute for those details. When reading a food-test headline, look for concentration and amount consumed, rather than treating a detectable result as a personal diagnosis. Sensible exposure reduction and careful reading do not require declaring every trace harmless or every contact dangerous.[13][12]

The active substance and the formulated product differ

Glyphosate is a herbicide active substance, while a commercial weedkiller also contains other ingredients. EPA calls these inert ingredients in a legal sense, but explicitly says inert does not mean nontoxic. Read active ingredients and the product label rather than assuming a brand name identifies one fixed formulation. A pure-compound experiment, a spray-product exposure and a food-residue measurement therefore ask different questions, even when glyphosate is relevant to all three.[2]

A food detection needs exposure and method context

FDA describes residues remaining on or in crops and its role enforcing EPA tolerances. These are food-specific regulatory concentrations, not one universal daily poisoning threshold. Testing also matters: FDA developed a selective method because its usual multi-residue methods did not adequately measure glyphosate. A broad pesticide panel cannot be assumed to cover it. Preserve the actual analyte, food, units, detection limits and consumption amount before interpreting a detection or absence.[1]

Evidence & uncertainty

This selected-source explanation preserves real scientific disagreement and recent review status. A cancer hazard, a mechanistic finding, a cohort association and a conditional regulatory approval are distinct findings. No independent systematic synthesis or personal risk calculation is claimed.[9]

Selected-source overview · Independent review pending

Published questions

Is glyphosate identical to a whole weedkiller product?

Selected-source overview · Independent review pending. Read the evidence context.

No. EPA distinguishes active and other ingredients. Formulation and label information matter; inert is a regulatory term that does not mean nontoxic.[2]

Evidence behind this answer
  • Basic Information about Pesticide Ingredients

    agency guidance or assessment · 2025
    Original official page and selected relevant passages inspected; no independent expert review · Active and inert ingredients; label identification; inert does not mean nontoxic

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does a food residue detection prove a harmful dose?

Selected-source overview · Independent review pending. Read the evidence context.

No. FDA describes food-specific tolerances and testing. Concentration, amount consumed and exposure context are needed; detection alone is not a clinical diagnosis.[1]

Evidence behind this answer
  • Questions and Answers on Glyphosate

    agency guidance or assessment · 2024
    Original official page and selected relevant passages inspected; no independent expert review · Herbicide definition; residues, EPA tolerances and selective analytical method; historical policy not treated as current decision

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Is all agency disagreement just hazard versus risk?

Selected-source overview · Independent review pending. Read the evidence context.

No. ECHA and IARC also reached differing hazard-classification conclusions. Criteria, study interpretation and weighting matter alongside the exposure question.[4][3]

Evidence behind this answer
  • RAC Opinion on harmonised classification and labelling of glyphosate

    agency guidance or assessment · 2022
    Original ECHA opinion in Slovenian government repository, selected classification and cancer-assessment passages inspected; full 151-page assessment not independently appraised · Opinion adopted 30 May 2022; classification table and carcinogenicity assessment around PDF pages 93-94

  • IARC Monograph on Glyphosate: questions and answers

    agency guidance or assessment · Date not stated
    Original official page and selected relevant passages inspected; no independent expert review · 2015 Group 2A basis; pure substance and formulations; human, animal and mechanistic evidence

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Did the applicator cohort settle every cancer question?

Selected-source overview · Independent review pending. Read the evidence context.

No. It found no apparent association for several major categories but an AML signal needing confirmation. Exposure measurement and statistical uncertainty limit conclusions.[6]

Evidence behind this answer
  • Glyphosate Use and Cancer Incidence in the Agricultural Health Study

    primary research · 2018
    Original research abstract and selected full-text results/discussion inspected; publication online 2017, journal issue 2018; cohort data not reanalyzed · Abstract, results and discussion: prospective applicator cohort, NHL findings, AML signal and limitations

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does oxidative stress show that someone has cancer?

Selected-source overview · Independent review pending. Read the evidence context.

No. The 2023 study measured biomarker associations, not cancer diagnosis or future cancer probability. It contributes mechanistic evidence with limits.[7]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Was EPA’s August 2026 notice a final safety assessment?

Selected-source overview · Independent review pending. Read the evidence context.

No. It released a literature search for feedback ahead of a forthcoming assessment. Its announced schedule does not establish that a final decision exists.[9]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Is a glyphosate-free weedkiller automatically gentler?

Selected-source overview · Independent review pending. Read the evidence context.

No. It identifies one absent ingredient, not the toxicity or exposure pattern of the replacement mixture. Current consumer Roundup formulations can use different herbicides. Check that bottle’s ingredients, directions and protective measures instead of transferring conclusions from glyphosate to the whole brand.[11][13]

Evidence behind this answer
  • Glyphosate: herbicide information factsheet

    university extension · Date not stated
    Original extension factsheet and dated update passages inspected · Introduction; August 2024 formulation update; March 2025 consumer-market context

  • Glyphosate General Fact Sheet

    public pesticide information · 2010
    Original official page and selected relevant passages inspected · Opening label advice; exposure routes; other ingredients; review date

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does detecting glyphosate in bread tell me the dose from spraying Roundup?

Selected-source overview · Independent review pending. Read the evidence context.

No. A food measurement concerns a residue concentration in that sample. Estimating dietary intake also requires the amount eaten; spraying introduces different contact routes and a formulated product. Detection alone does not establish a harmful personal dose.[12]

Evidence behind this answer
  • Food safety: Pesticide residue

    agency explanation · 2016
    Original official page and selected relevant passages inspected · Hazard versus risk; dose and route; dietary residue assessment

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Did EPA’s September 2026 announcement settle the cancer question?

Selected-source overview · Independent review pending. Read the evidence context.

No. It announced scientific coordination and further evaluation within the registration review, including formulations, dietary and occupational exposure. It did not issue a completed updated human-health assessment or make a new individual cancer-risk finding.[15]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

IARC identified a cancer hazard

IARC classified glyphosate in Group 2A in 2015, drawing on limited human evidence, sufficient animal evidence and strong genotoxicity evidence. Its explanation includes both pure glyphosate and formulations; reducing its conclusion to only a co-formulant effect misstates the assessment. Group 2A describes the strength of hazard evidence, rather than a probability from one meal. Occupational exposure studies and trace dietary residues cannot automatically share one personal risk estimate.[3]

Agency conclusions answer overlapping but distinct questions
AssessmentScope and conclusion
IARC 2015Cancer-hazard classification: Group 2A[3]
ECHA 2022EU classification criteria: no cancer classification warranted[4]
EFSA 2023Representative-use risk review; critical-concern definition and unfinished issues[5]
EPA August 2026Literature search for an upcoming assessment; not its final conclusion[9]

The large applicator cohort found a mixed pattern

The Agricultural Health Study followed licensed pesticide applicators and reported no association apparent for solid tumors or lymphoid cancers overall, including non-Hodgkin lymphoma, in its 2018 analysis. It also found an acute myeloid leukemia signal among the highest exposed groups requiring confirmation. The unlagged estimate had a wide interval including no association. Self-reported exposure, missing information and many cancer comparisons limit interpretation. This observational study neither proves no possible hazard nor measures the cancer effect of ordinary food residues.[6]

A mechanistic association is not a cancer diagnosis

A 2023 Agricultural Health Study subcohort included 268 male farmers and 100 male nonfarmers. Urinary glyphosate was associated with certain oxidative-stress biomarkers. This adds human mechanistic evidence, but it does not establish which participants developed cancer or supply a disease-predictive urine cutoff. Co-exposures, timing and an observational design matter. A biomarker result should not be converted directly into a percentage cancer risk or an indication for a detox treatment.[7]

New animal results require appraisal in context

A 2025 experiment administered glyphosate or two formulations to rats from prenatal life through 104 weeks and reported increased tumors at multiple sites. It adds direct animal evidence distinct from the human cohort and biomarker study. The formulations, sustained doses, pathology and statistical comparisons require assessment before translating findings to people. Matching a dose to a regulatory benchmark does not turn a rat result into a measured human effect at that dose.[8]

Hazard versus risk does not explain all disagreement

ECHA's 2022 hazard-classification opinion did not find cancer classification warranted under EU criteria, while IARC reached a different hazard conclusion. Thus the disagreement is not explained solely by one agency asking about hazard and another about exposure. Study appraisal, weighting and classification criteria also matter. EFSA's 2023 no-critical-concern finding has a technical scope: it still identified unfinished consumer dietary, impurity and formulation-component questions. Neither headline supplies proof of zero uncertainty or unrestricted safety.[4][5][3]

An announced review is not a completed verdict

In August 2026 EPA released a literature-search document for comment to inform a forthcoming human-health assessment, then scheduled for late 2026. A study list and proposed review process are not the completed conclusions. EPA’s older assessment therefore does not represent the final outcome of this ongoing review. Actual revised decisions, rather than an assumed timetable, are relevant future editorial checks.[9]

Approval has conditions and a jurisdiction

The European Commission describes active-substance approval through 15 December 2033 with conditions and restrictions; national authorities separately authorize products. It also describes requesting evaluation of newer study data. Approval is a legal status, not permission for every formulation or use. Follow the product’s instructions and applicable restrictions, distinguishing occupational application from dietary residues when interpreting evidence.[10]

References

  1. Questions and Answers on Glyphosate

    Agency guidance or assessment

    US FDA · Content/publication date: 2024
    Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected; no independent expert review
    Cited sections: Herbicide definition; residues, EPA tolerances and selective analytical method; historical policy not treated as current decision

    Publication or content date is distinct from access date; no claim of continuous monitoring.

  2. Basic Information about Pesticide Ingredients

    Agency guidance or assessment

    US EPA · Content/publication date: 2025
    Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected; no independent expert review
    Cited sections: Active and inert ingredients; label identification; inert does not mean nontoxic

    Publication or content date is distinct from access date; no claim of continuous monitoring.

  3. IARC Monograph on Glyphosate: questions and answers

    Agency guidance or assessment

    IARC/WHO · Content/publication date: not stated
    Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected; no independent expert review
    Cited sections: 2015 Group 2A basis; pure substance and formulations; human, animal and mechanistic evidence

  4. RAC Opinion on harmonised classification and labelling of glyphosate

    Agency guidance or assessment

    ECHA Committee for Risk Assessment · Content/publication date: 2022
    Accessed: 2026-10-13 UTC · Original ECHA opinion in Slovenian government repository, selected classification and cancer-assessment passages inspected; full 151-page assessment not independently appraised
    Cited sections: Opinion adopted 30 May 2022; classification table and carcinogenicity assessment around PDF pages 93-94

    Publication or content date is distinct from access date; no claim of continuous monitoring.

  5. Glyphosate: no critical areas of concern; data gaps identified

    Agency guidance or assessment

    EFSA · Content/publication date: 2023
    Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected; no independent expert review
    Cited sections: 2023 review definition of critical concern; unfinished consumer/impurity assessments and formulation-component gap

    Publication or content date is distinct from access date; no claim of continuous monitoring.

  6. Glyphosate Use and Cancer Incidence in the Agricultural Health Study

    Primary research

    Andreotti G and colleagues / JNCI · Content/publication date: 2018
    Accessed: 2026-10-13 UTC · Original research abstract and selected full-text results/discussion inspected; publication online 2017, journal issue 2018; cohort data not reanalyzed
    Cited sections: Abstract, results and discussion: prospective applicator cohort, NHL findings, AML signal and limitations

    Publication or content date is distinct from access date; no claim of continuous monitoring.

  7. Glyphosate exposure and urinary oxidative stress biomarkers in the Agricultural Health Study

    Primary research

    Chang VC and colleagues / JNCI · Content/publication date: 2023
    Accessed: 2026-10-13 UTC · Original research abstract indexed by PubMed inspected; complete protocol and participant-level data not independently appraised
    Cited sections: Abstract: 268 male farmers and 100 nonfarmers; biomarker associations, not cancer incidence

    Publication or content date is distinct from access date; no claim of continuous monitoring.

  8. Carcinogenic effects of prenatal-to-lifetime glyphosate and herbicide exposure in Sprague-Dawley rats

    Primary research

    Panzacchi S and colleagues / Environmental Health · Content/publication date: 2025
    Accessed: 2026-10-13 UTC · Original primary-study abstract and selected methods/results inspected; no independent pathology or statistical reanalysis
    Cited sections: Abstract and methods: pure compound/two formulations; prenatal-to-104-week rat exposure; tumor findings

    Publication or content date is distinct from access date; no claim of continuous monitoring.

  9. EPA Releases Glyphosate Human Health Open Literature Search for Public Feedback

    Agency guidance or assessment

    US EPA · Content/publication date: 2026
    Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected; no independent expert review
    Cited sections: August 25, 2026 notice; literature-search release precedes forthcoming health assessment

    Publication or content date is distinct from access date; no claim of continuous monitoring.

  10. Glyphosate: status and questions and answers

    Agency guidance or assessment

    European Commission · Content/publication date: not stated
    Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected; no independent expert review
    Cited sections: Approval to December 2033 with restrictions; national product authorization; new-study evaluation request

    Publication or content date is distinct from access date; no claim of continuous monitoring.

  11. Glyphosate: herbicide information factsheet

    University extension

    NC State Extension · Content/publication date: not stated
    Accessed: 2026-10-15 UTC · Original extension factsheet and dated update passages inspected
    Cited sections: Introduction; August 2024 formulation update; March 2025 consumer-market context

    Used for ingredient/brand distinction only. Historical litigation and broad cancer summaries on the page are not used as current clinical evidence.

  12. Food safety: Pesticide residue

    Agency explanation

    WHO · Content/publication date: 2016
    Accessed: 2026-10-15 UTC · Original official page and selected relevant passages inspected
    Cited sections: Hazard versus risk; dose and route; dietary residue assessment

    Dated methodological explanation, not a continuously updated glyphosate assessment.

  13. Glyphosate General Fact Sheet

    Public pesticide information

    National Pesticide Information Center / Oregon State University · Content/publication date: 2010
    Accessed: 2026-10-15 UTC · Original official page and selected relevant passages inspected
    Cited sections: Opening label advice; exposure routes; other ingredients; review date

    2019 guidance; newer cancer assessments discussed separately.

  14. Glyphosate: 8 September 2026 RAC update

    Agency assessment update

    European Chemicals Agency · Content/publication date: 2026
    Accessed: 2026-10-15 UTC · Indexed original official update passages inspected; direct page retrieval returned 403
    Cited sections: 8 September 2026 update on Ramazzini data; no change to 2022 classification conclusion

    Indexed English original text verified with targeted searches; an indexed Italian version confirms the same update. Translations and tracking URLs are not independent evidence or separate budgets.

  15. EPA and HHS Announce New Scientific Partnership to Strengthen Glyphosate Review

    Agency process update

    US EPA · Content/publication date: 2026
    Accessed: 2026-10-15 UTC · Original official page and selected relevant passages inspected
    Cited sections: 22 September 2026 announcement; scope, ongoing assessment and no predetermined outcome

    Announcement is not a completed updated risk assessment. This release anticipates early 2027 completion, while the main topic page updated August 2026 says late 2026; no precise completion promise is repeated.

Scope & review

Population
General readers; vulnerable populations and source-specific exposure settings are distinguished
Exposure or intervention
Glyphosate
Comparison
Chemical forms, exposure routes, source-specific populations and jurisdiction-specific rules
Outcomes
Definitions, categories, exposure interpretation, practical questions and uncertainty
Timeframe
Selected historical and current sources checked 2026-10-13; publication dates are recorded separately
Jurisdiction
US and explicitly identified international guidance; local requirements differ

Bounded selected-source educational explanation. Agency assessments and editorial interpretation are distinguished; no exhaustive search, independent systematic synthesis or qualified medical review.

Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.

Revision history
  • 2026-10-13 UTC: Added definition-first explainer with exposure distinctions, source-linked questions and uncertainty.
  • 2026-10-15 UTC: Added the plain-English series explanation, practical questions and selected primary sources; independent review remains pending.

What this article still leaves open

  • No product certification, urine-test diagnosis, lawsuit assessment or personal cancer-risk estimate is supplied.
  • New assessment conclusions, formulation-specific evidence and independent reappraisal of animal and human studies remain outstanding.
Suggest a correction

Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.

More in the plain-English series

Keep making sense of it.

Explore Products & safety explanations See every explanation

Explore the topic map

Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.